Literature DB >> 1290269

The metabolic effects of thermal injury.

E E Tredget1, Y M Yu.   

Abstract

Major thermal injury is associated with extreme hypermetabolism and catabolism as the principal metabolic manifestations encountered following successful resuscitation from the shock phase of the burn injury. Substrate and hormonal measurements, indirect calorimetry, and nitrogen balance are biochemical metabolic parameters which are useful and more readily available biochemical parameters worthy of serial assessment for the metabolic management of burn patients. However, the application of stable isotopes with gas chromatography/mass spectroscopy and more recently, new immunoassays for growth factors and cytokines has increased our understanding of the metabolic manifestations of severe trauma. The metabolic response to injury in burn patients is biphasic wherein the initial ebb phase is followed by a hypermetabolic and catabolic flow phase of injury. The increased oxygen consumption/metabolic rate is in part fuelled by evaporative heat loss from wounds of trauma victims, but likely also by a direct central effect of inflammation upon the hypothalamus. Although carbohydrates in the form of glucose appear to be an important fuel source following injury, a maximum of 5-6 mg/kg/min only is beneficial. Burn patients have accelerated gluconeogenesis, glucose oxidation, and plasma clearance of glucose. Additionally, considerable futile cycling of carbohydrate intermediates occurs which includes anaerobic lactate metabolism and Cori cycle activity arising from wound metabolism of glucose and other substrates. Similarly, accelerated lipolysis and futile fatty acid cycling occurs following burn injury. However, recent evidence suggests that lipids in the diet of burned and other injured patients serve not only as an energy source, but also as an important immunomodulator of prostaglandin metabolism and other immune responses. Amino acid metabolism in burn patients is characterized by increased oxidation, urea synthesis, and protein breakdown which is prolonged and difficult to reduce with current nutritional therapy. However, the current goal of nutritional support is to optimize protein synthesis. Specific unique requirements may exist for supplemental glutamine and arginine following burn injury but further research is needed before enhanced branched chain amino acids supplements can be recommended for burn patients. Recent research investigations have revealed the importance of enteral feeding to enhance mucosal defense against gut bacteria and endotoxin. Similarly, research has demonstrated that many of the metabolic perturbations of burns and sepsis may be due, at least in part, to inflammatory cytokines. Investigation of their pathogenesis and mechanism of action both at a tissue and a cellular level offer important prospects for improved understanding and therapeutic control of the metabolic disorders of burn patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1290269     DOI: 10.1007/bf02067117

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  157 in total

1.  Intestinal metabolism of glutamine and glutamate from the lumen as compared to glutamine from blood.

Authors:  H G Windmueller; A E Spaeth
Journal:  Arch Biochem Biophys       Date:  1975-12       Impact factor: 4.013

Review 2.  Gut glutamine metabolism.

Authors:  W W Souba; K Herskowitz; R M Salloum; M K Chen; T R Austgen
Journal:  JPEN J Parenter Enteral Nutr       Date:  1990 Jul-Aug       Impact factor: 4.016

3.  Report of a research workshop: branched-chain amino acids in stress and injury.

Authors:  M F Brennan; F Cerra; J M Daly; J E Fischer; L L Moldawer; R J Smith; E Vinnars; R Wannemacher; V R Young
Journal:  JPEN J Parenter Enteral Nutr       Date:  1986 Sep-Oct       Impact factor: 4.016

4.  The gut origin septic states in blunt multiple trauma (ISS = 40) in the ICU.

Authors:  J R Border; J Hassett; J LaDuca; R Seibel; S Steinberg; B Mills; P Losi; D Border
Journal:  Ann Surg       Date:  1987-10       Impact factor: 12.969

5.  L-arginine is a precursor for nitrate biosynthesis in humans.

Authors:  C D Leaf; J S Wishnok; S R Tannenbaum
Journal:  Biochem Biophys Res Commun       Date:  1989-09-15       Impact factor: 3.575

6.  Does increased evaporative water loss cause hypermetabolism in burned patients?

Authors:  B E Zawacki; K W Spitzer; A D Mason; L A Johns
Journal:  Ann Surg       Date:  1970-02       Impact factor: 12.969

7.  Supplemental arginine, wound healing, and thymus: arginine-pituitary interaction.

Authors:  A Barbul; G Rettura; E Prior; S M Levenson; E Seifter
Journal:  Surg Forum       Date:  1978

Review 8.  Medium chain triglycerides and structured lipids.

Authors:  V K Babayan
Journal:  Lipids       Date:  1987-06       Impact factor: 1.880

9.  Hemodynamic effects of intravenous 20% soy oil emulsion following coronary bypass surgery.

Authors:  R M Abel; D Fisch; M L Grossman
Journal:  JPEN J Parenter Enteral Nutr       Date:  1983 Nov-Dec       Impact factor: 4.016

10.  Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog.

Authors:  K J Tracey; S F Lowry; T J Fahey; J D Albert; Y Fong; D Hesse; B Beutler; K R Manogue; S Calvano; H Wei
Journal:  Surg Gynecol Obstet       Date:  1987-05
View more
  26 in total

1.  The effects of injury magnitude on the kinetics of the acute phase response.

Authors:  Graciela Bauzá; Glenn Miller; Neema Kaseje; Nathan A Wigner; Zhongyan Wang; Louis C Gerstenfeld; Peter A Burke
Journal:  J Trauma       Date:  2011-04

2.  Alcohol Intoxication and the Postburn Gastrointestinal Hormonal Response.

Authors:  Juan-Pablo Idrovo; Jill A Shults; Brenda J Curtis; Michael M Chen; Elizabeth J Kovacs
Journal:  J Burn Care Res       Date:  2019-10-16       Impact factor: 1.845

3.  Influence of metformin on glucose intolerance and muscle catabolism following severe burn injury.

Authors:  Dennis C Gore; Steven E Wolf; Arthur Sanford; David N Herndon; Robert R Wolfe
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

4.  Burn injury causes mitochondrial dysfunction in skeletal muscle.

Authors:  Katie E Padfield; Loukas G Astrakas; Qunhao Zhang; Suresh Gopalan; George Dai; Michael N Mindrinos; Ronald G Tompkins; Laurence G Rahme; A Aria Tzika
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-04       Impact factor: 11.205

5.  Contemporary Burn Survival.

Authors:  Karel D Capek; Linda E Sousse; Gabriel Hundeshagen; Charles D Voigt; Oscar E Suman; Celeste C Finnerty; Kristofer Jennings; David N Herndon
Journal:  J Am Coll Surg       Date:  2018-03-09       Impact factor: 6.113

6.  Pathway analysis of liver metabolism under stressed condition.

Authors:  Mehmet A Orman; Francois Berthiaume; Ioannis P Androulakis; Marianthi G Ierapetritou
Journal:  J Theor Biol       Date:  2010-12-14       Impact factor: 2.691

7.  17β-Estradiol reappropriates mass lost to the hypermetabolic state in thermally injured rats.

Authors:  Kareem R Abdelfattah; Joshua W Gatson; David L Maass; Steven E Wolf; Joseph P Minei; Jane G Wigginton
Journal:  J Surg Res       Date:  2012-06-20       Impact factor: 2.192

Review 8.  The hepatic response to thermal injury: is the liver important for postburn outcomes?

Authors:  Marc G Jeschke
Journal:  Mol Med       Date:  2009-04-10       Impact factor: 6.354

9.  The clinical significance of the MIF homolog d-dopachrome tautomerase (MIF-2) and its circulating receptor (sCD74) in burn.

Authors:  Bong-Sung Kim; Christian Stoppe; Gerrit Grieb; Lin Leng; Maor Sauler; David Assis; David Simons; Arne Hendrick Boecker; Wibke Schulte; Marta Piecychna; Stephan Hager; Jürgen Bernhagen; Norbert Pallua; Richard Bucala
Journal:  Burns       Date:  2016-05-18       Impact factor: 2.744

10.  Effect of low-level laser therapy on types I and III collagen and inflammatory cells in rats with induced third-degree burns.

Authors:  Franciane B Fiório; Regiane Albertini; Ernesto Cesar Pinto Leal-Junior; Paulo de Tarso Camillo de Carvalho
Journal:  Lasers Med Sci       Date:  2013-05-16       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.